reference/7478384

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7478384

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	2073-4409
issueIdentifier	9
pageRange	1089-
publicationName	Cells
startingPage	1089
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c9715a34c9ccde7ccc72cadee3277b94 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06062464e4efbdf64c21a1197c5e9e54 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4289784abb0e9ea94c73f7da17d220c0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bd2bbe1c31bea34ce6f443cdc675ae59 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_db2ec0c9463097e28d5e0a52e4edf802 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_86e506da6a7ca3a4e31a94f240496302 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_89716198cee21f7b9f75dd2f8beb6491 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_150e1718129472efbb16b594884e4a53
bibliographicCitation	Chamcheu JC, Esnault S, Adhami VM, Noll AL, Banang-Mbeumi S, Roy T, Singh SS, Huang S, Kousoulas KG, Mukhtar H. Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models. Cells. 2019 Sep 15;8(9). PMID: 31540162; PMCID: PMC6770767.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3239-1072 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f79be366620a2a72f1dfdd7d78de1a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3101-7705 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4185dbc015f6d2e19f818b1e3836603 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3141-0224 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c521e52d8730e9a005063b7dae9593a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66da634edc58e8ead667a3e676ea840b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3927-5664 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f341711b2818f03720d3322ce4ead64 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2048-4570 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f06b27df98de750d60ba46fb96bc71df
date	2019-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/31540162 https://pubmed.ncbi.nlm.nih.gov/PMC6770767 https://doi.org/10.3390/cells8091089
isPartOf	https://portal.issn.org/resource/ISSN/2073-4409 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40953
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Fisetin, a 3,7,3′,4′-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models
discusses	http://id.nlm.nih.gov/mesh/M0444535 http://id.nlm.nih.gov/mesh/M0150739 http://id.nlm.nih.gov/mesh/M0060378 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0068970 http://id.nlm.nih.gov/mesh/M0469193
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008954 http://id.nlm.nih.gov/mesh/D058570Q000037 http://id.nlm.nih.gov/mesh/D011565Q000188 http://id.nlm.nih.gov/mesh/D012867Q000187 http://id.nlm.nih.gov/mesh/D007249Q000188 http://id.nlm.nih.gov/mesh/D020935Q000187 http://id.nlm.nih.gov/mesh/D005419Q000494 http://id.nlm.nih.gov/mesh/D051057Q000037
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011565Q000378 http://id.nlm.nih.gov/mesh/D015603Q000187 http://id.nlm.nih.gov/mesh/D002470Q000187 http://id.nlm.nih.gov/mesh/D002478 http://id.nlm.nih.gov/mesh/D011565Q000473 http://id.nlm.nih.gov/mesh/D007249Q000473 http://id.nlm.nih.gov/mesh/D058570Q000378 http://id.nlm.nih.gov/mesh/D012867Q000473 http://id.nlm.nih.gov/mesh/D019869Q000378 http://id.nlm.nih.gov/mesh/D007249Q000378 http://id.nlm.nih.gov/mesh/D015603Q000378 http://id.nlm.nih.gov/mesh/D051057Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D044948
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9238 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9826034 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f7d7fa31aa868be14ce6001ac82fcf7 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e7c5ddf51598d2addf7ca974bdff068d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b417e023e679477b7a58dd6b19d2a8b5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07edfd5399a4297179b0eb6e7ec0142a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9f9895466bf4df30d3aeb755694ec952 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8cb7e80809cc72f74cddd6d498451b46 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_118dd6abf266102dccb53d8fc658affb http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4364cf21c8950e29e0eef7c8157371bc http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab9bc7ce433266ca5b4543e538aeed73 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8094 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9007 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8154

Total number of triples: 92.